Evening the Score: Targeting SARS-CoV-2 Protease Inhibition in Graph Generative Models for Therapeutic Candidates

Abstract

We examine a pair of graph generative models for the therapeutic design of novel drug candidates targeting SARS-CoV-2 viral proteins. Due to a sense of urgency, we chose well-validated models with unique strengths: an autoencoder that generates molecules with similar structures to a dataset of drugs with anti-SARS activity and a reinforcement learning algorithm that generates highly novel molecules. During generation, we explore optimization toward several design targets to balance druglikeness, synthetic accessability, and anti-SARS activity based on \icfifty. This generative framework\footnote{https://github.com/exalearn/covid-drug-design} will accelerate drug discovery in future pandemics through the high-throughput generation of targeted therapeutic candidates.

arXiv admin note: substantial text overlap with arXiv:2102.04977

References in corpus (8)

• Playing Atari with Deep Reinforcement Learning
• Neural Message Passing for Quantum Chemistry
• Junction Tree Variational Autoencoder for Molecular Graph Generation
• DeepPurpose: a Deep Learning Library for Drug-Target Interaction Prediction
• SMILES Enumeration as Data Augmentation for Neural Network Modeling of Molecules
• Multi-Objective Molecule Generation using Interpretable Substructures
• Artificial Intelligence based Autonomous Molecular Design for Medical Therapeutic: A Perspective
• Designing a Prospective COVID-19 Therapeutic with Reinforcement Learning